Muhammad Reva Aditya

Mr. Muhammad Reva Aditya

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2025 in US Cardiology Review
Verified
Journal Article
Open access
PDF file
WWWilliam Wiradinata
William Wiradinata
ASAnita Dominique Subali
Anita Dominique Subali
Muhammad Reva AdityaMuhammad Reva Aditya
Muhammad Reva Aditya
Exercise-induced long QT may mimic congenital long QT syndrome (LQTS), risking misdiagnosis and unnecessary treatment. This scoping review explores its reversibility through detraining and differentiation from congenital LQTS. A systematic search of five databases identified six studies involving 196 subjects. Results showed that exercise-induced long QT is reversible, with QT intervals normalizing after detraining, typically over 1–6 months. Unlike congenital LQTS, affected athletes often lacked genetic mutations or family histories linked to the condition. The difference between congenital LQTS and exercise-induced long QT lies in the reversibility of QT interval prolongation. In those with exercise-induced long QT, the prolonged QT interval would return to normal levels with detraining, unlike in congenital LQTS. Further long-term follow-up is needed to assess the potential arrhythmic risk associated with re-exposure to intensive training. Additionally, negative genetic testing and absence of family history do not entirely exclude congenital LQTS nor indicate benignity, emphasizing the need for careful clinical assessment beyond these factors.

Verified
Journal Article
Open access
PDF file
Fahrul NurkolisFahrul Nurkolis
Fahrul Nurkolis
Nurlinah AmaliaNurlinah Amalia
Nurlinah Amalia
Yosi Yohanes Putra TandiYosi Yohanes Putra Tandi
Yosi Yohanes Putra Tandi
Ariq Fadhil AthallahAriq Fadhil Athallah
Ariq Fadhil Athallah
Muhammad Reva AdityaMuhammad Reva Aditya
Muhammad Reva Aditya
RTRaymond R. Tjandrawinata
Raymond R. Tjandrawinata
The rs1801133 (C677T) polymorphism of the methylenetetrahydrofolate reductase (MTHFR) gene has been linked to type 2 diabetes (T2D) risk. This study aimed to assess the association between rs1801133 genotypes (CC, CT, TT) and T2D across multiethnic populations and to identify genotype- and region-specific risks. A global meta-epidemiological analysis was conducted using data from 19 studies comprising 6479 participants from Asia, Africa, Europe, and America. Odds ratios (OR) and 95% confidence intervals (CIs) were calculated using random-effects models. Subgroup analyses by region were also performed. The results of the CC vs. CT dominant genetic model were OR 95% CI = 0.63 (0.46–0.87); p = 0.005; the CC vs. TT genetic recessive model yielded OR 95% CI = 0.59 (0.38–0.91); p = 0.02; and the CT vs. TT codominance genetic model yielded OR 95% CI = 0.95 (0.65–1.37); p = 0.78. Based on the subgroup analysis, the CC genotype is predominantly associated with an increased risk of T2D in both Africa and Europe. From this study, the CC genotype was proven to be highly contributory to T2D risk compared to the CT and TT genotypes. These findings highlight the need for ethnicity-informed genetic screening and targeted prevention strategies in global diabetes management.

24 February 2026 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
Muhammad Reva AdityaMuhammad Reva Aditya
Muhammad Reva Aditya
MHMichael Owen Hogipranata
Michael Owen Hogipranata
ASArtha Maressa Theodora Simanjuntak
Artha Maressa Theodora Simanjuntak
DRDerren David Christian Homenta Rampengan
Derren David Christian Homenta Rampengan
KKKanandya Kizzandy
Kanandya Kizzandy
HSHikmawan Wahyu Sulistomo
Hikmawan Wahyu Sulistomo

5 August 2026 in Probiotics and Antimicrobial Proteins
Verified
Journal Article
Closed access
PDF file
Muhammad Reva AdityaMuhammad Reva Aditya
Muhammad Reva Aditya
FWFrengki Prabowo Saputro Wijayanto
Frengki Prabowo Saputro Wijayanto
ASArtha Maressa Theodora Simanjuntak
Artha Maressa Theodora Simanjuntak
MHMichael Owen Hogipranata
Michael Owen Hogipranata
RMRizki Hari Mulia
Rizki Hari Mulia
HSHikmawan Wahyu Sulistomo
Hikmawan Wahyu Sulistomo

1 October 2026
Verified
Journal Article
Open access
PDF file
DYDewangga Yudisthira
Dewangga Yudisthira
MKMuhammad Rico Abdul Karim
Muhammad Rico Abdul Karim
AMAthaya Rahmanardi Muhammad
Athaya Rahmanardi Muhammad
Muhammad Reva AdityaMuhammad Reva Aditya
Muhammad Reva Aditya
AAAzril Okta Ardiansyah
Azril Okta Ardiansyah
AAAndreas Andrianto
Andreas Andrianto
Background: Postoperative pain remains common after surgery, and opioid-related adverse effects motivate multimodal alternatives. The serratus plane block (SPB) is used for breast surgery, but its comparative benefit remains uncertain. Methods: We searched PubMed, the Cochrane Library, and ProQuest for English-language randomized trials and cohort studies published between January 2019 ...

16 December 2025 in Indonesian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
FPFlorentina Dewi Pramesuari
Florentina Dewi Pramesuari
Muhammad Reva AdityaMuhammad Reva Aditya
Muhammad Reva Aditya
MMMustika Mahbubi
Mustika Mahbubi
Background: Refractory angina (RA) is a chronic condition unresponsive to standard treatments like PCI or CABG, leaving limited options for many patients. Cardiac shockwave therapy (CSWT) is a novel, noninvasive approach that enhances myocardial perfusion through microvascular regeneration. This systematic review and meta-analysis evaluate the effectiveness of CSWT in managing RA. Methods: A comprehensive literature search was conducted using electronic databases (Cochrane, PubMed, and ScienceDirect), including comparative studies with controls that evaluated CSWT in RA patients between 2010 and 2024. Studies not in English, with irrelevant outcomes, or lacking full-text access, were excluded. Data were extracted and analyzed using a random-effects model to address heterogeneity. Results: Seven studies, including 3 randomized controlled trials (RCTs) and 4 observational studies, with a total of 417 patients were analyzed. CSWT demonstrated significant improvements in multiple clinical outcomes. CSWT reduces angina severity in CSWT reduces angina severity in CCS grade (MD -0.76, 95% CI -0.97, -0.55, P < 0.00001) and in NYHA class (MD -0.62, 95% CI -0.95, -0.30, P = 0.0002), increased the 6- Minute Walk Test (6MWT) distance by 57.63 meters (MD 57.63, 95% CI 16.71, 98.54, P = 0.006), increased SAQ scores by 10.96 points (MD 10.96, 95% CI 1.66, 20.26, P = 0.02), improved LVEF by 4.43% (MD 4.43, 95% CI: 2.66 to 6.21, P< 0.01), and decreased nitroglycerin usage by 1.62 intake per week (MD -1.62, 95% CI -2.61, -0.62, P = 0.001). However, there was no significant difference in LVEDD between the two groups. Conclusion: CSWT appears to be a promising therapeutic option for patients with RA, demonstrating improvement in CCS angina class, NYHA class, 6-min walk test distances, SAQ score, LVEF, and reduces nitroglycerin usage. Keyword: Cardiac Shockwave Therapy, Refractory Angina, Non-invasive Cardiac Therapy, Chronic Angina Treatment, Innovative Angina Therapies